Bausch Health Companies (BHC) Set to Announce Earnings on Wednesday

Bausch Health Companies (TSE:BHC) is scheduled to post its quarterly earnings results after the market closes on Wednesday, October 30th. Analysts expect Bausch Health Companies to post earnings of C$1.45 per share for the quarter.

Bausch Health Companies (TSE:BHC) last issued its earnings results on Thursday, August 1st. The company reported C$1.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of C$1.22. The business had revenue of C$3.29 billion for the quarter, compared to analyst estimates of C$3.20 billion. Bausch Health Companies had a negative net margin of 5.12% and a negative return on equity of 2,304.54%.

Bausch Health Companies Stock Up 2.0 %

Shares of TSE BHC opened at C$11.39 on Tuesday. The firm has a market cap of C$4.18 billion, a PE ratio of -6.51, a P/E/G ratio of 0.21 and a beta of 0.77. Bausch Health Companies has a 12-month low of C$5.45 and a 12-month high of C$15.43. The company’s fifty day simple moving average is C$9.58 and its 200 day simple moving average is C$9.87. The company has a quick ratio of 0.58, a current ratio of 1.19 and a debt-to-equity ratio of 7,583.76.

Analysts Set New Price Targets

Several research analysts recently issued reports on BHC shares. Raymond James upgraded shares of Bausch Health Companies to a “hold” rating in a report on Wednesday, July 10th. Evercore ISI upgraded shares of Bausch Health Companies to a “hold” rating in a report on Tuesday, October 15th.

Insider Activity

In related news, Senior Officer Seana Lynne Carson sold 13,370 shares of the firm’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of C$8.38, for a total transaction of C$112,087.40. 11.28% of the stock is currently owned by corporate insiders.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.